Frequency of Fluoroquinolone and Aminoglycoside Resistance Online Probe Assay in Multidrug-Resistant Tuberculosis Patients

Authors

  • Qasim Nawaz, Sajjad Naseer, Imran Khan, Asad Ali, Akhlaq Ahmad, Aima Hameed

DOI:

https://doi.org/10.53350/pjmhs2023175617

Abstract

Background: The resistance of tuberculosis to anti-tuberculous therapy is a severe public health concern all over the globe. The most common and important cause of resistance to anti-tuberculous therapy is poor patient compliance with or inappropriate therapy dosing.

Objective: In order to evaluate the prevalence of resistance to commonly used 2nd-line anti-tuberculous drugs, an online probe assay was conducted among patients diagnosed with multi-drug-resistant tuberculosis. This study specifically focused on patients who were receiving treatment with fluoroquinolones and aminoglycosides and were seeking care at Lady Reading Hospital, a tertiary care facility located in Peshawar.

Methods: This study was conducted at the Department of Pulmonology ward of Lady Reading Hospital, Peshawar, from Jan 2021 to Jan 2022, six months in which a total of 150 patients were observed to determine the frequency of common 2nd-line standard anti-tuberculous drugs resistance online probe assay in patients with multidrug-resistant tuberculosis. flouroquinolones and . Non-probability sequential sampling was the method used for sampling.

Results: This study, conducted at the Department of Pulmonology ward of Lady Reading Hospital in Peshawar, employed a cross-sectional design. The objective was to assess the prevalence of resistance to standard 2nd-line anti-tuberculous drugs among patients with multidrug-resistant tuberculosis using online probe assays. A total of 150 patients were included in the analysis (n = 15-24). The age distribution of the participants was as follows: 52 patients (34.7%) were between 25-34 years old, 34 patients (22.7%) were between 35-44 years old, and 35 patients (23.3%) were between 45-54 years old (Table No. 1). The mean age was found to be 33.76 years, with a standard deviation of 16.42. In terms of gender, 66 patients (44%) were male and 84 patients (56%) were female (Figure No. 1). Sputum culture conversion at 2 months was observed in 50.7% of the cases, while it was absent in 49.3% (Table No. 3). Additionally, previous tuberculosis treatment was reported by 5 patients (0.7%), while the majority (99.3%) had no history of previous treatment (Table No. 6).

Conclusion: The use of fluoroquinolones standard antia was the A considerable percentage of resistance was discovered in the nation's first attempt to test the extent of 2nd-line medication resistance among MDR-TB isolates. Even though there were 84 females present, it's interesting that none of the isolates fit the requirements for XDR-TB. A crucial indicator of the probable severe pan resistance development of XDR-TB is the use of first-line drugs. While the national TB control plans are put into place, MDR-TB cases must be closely monitored. The short: Regularity, proximity

Keywords: 2nd-line standard anti-tuberculous drugs resistance, multidrug-resistant tuberculosis. Tuberculosis fluoroquinolones and aminoglycosides,

Downloads

How to Cite

Qasim Nawaz, Sajjad Naseer, Imran Khan, Asad Ali, Akhlaq Ahmad, Aima Hameed. (2023). Frequency of Fluoroquinolone and Aminoglycoside Resistance Online Probe Assay in Multidrug-Resistant Tuberculosis Patients. Pakistan Journal of Medical & Health Sciences, 17(05), 617. https://doi.org/10.53350/pjmhs2023175617